54
Participants
Start Date
July 31, 2008
Primary Completion Date
December 31, 2011
Study Completion Date
December 31, 2012
Neoadjuvant chemotherapy
Docetaxel 75 mg/m2, day 1 Epirubicin 80 mg/m2, day 1 Cyclophosphamide 500 mg/m2, day 1 Navelbine 25 mg/M2 in 250 cc NS over 60 min on day 1 and day 8 Bevacizumab 5 mg/kg in 100 cc NS over 90 min day 1 and day 8 Capecitabine 825 mg/M2 p.o. bid from day 1-14. Trastuzumab
Chemotherapy
Neoadjuvant chemotherapy
Neoadjuvant chemotherapy
Experimental chemotherapy regimen
Auxilio Mutuo Cancer Center, San Juan
Collaborators (1)
Sanofi
INDUSTRY
Auxilio Mutuo Cancer Center
OTHER